| Dr Estelle Alexis Rutledge, MD | |
|
38 Villa Vista Loop, Little Rock, AR 72204-6708 | |
| (501) 960-1390 | |
| Not Available |
| Full Name | Dr Estelle Alexis Rutledge |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 20 Years |
| Location | 38 Villa Vista Loop, Little Rock, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649465386 | NPI | - | NPPES |
| 1649465386 | Other | AR | BCBS |
| 177675001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | E6039 (Arkansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Obhg Louisiana Llc | 9234443250 | 4 |
News Archive
Improving diagnosis and treatment for individuals with autism has been the focus of a growing body of research. New information from these studies led the American Academy of Child and Adolescent Psychiatry to revise key parameters for evaluating and treating autism. Researchers led by Yale Child Study Center director Fred Volkmar, M.D., have published the new practice parameters in the Feb. issue of the Journal of the American Academy of Child and Adolescent Psychiatry.
A University of Colorado Cancer Center study published in the journal Pediatric Blood & Cancer shows that pediatric cancer patients who receive antibiotics within 60 minutes of reporting fever and showing neutropenia (low neutrophil count), go on to have decreased intensive care consultation rate and lower mortality compared with patients who receive antibiotics outside the 60-minute window.
With the number of deaths caused by high blood pressure on the rise in the United States, the American Medical Association is joining the American Heart Association to increase public awareness of this "silent killer."
The Patient-Centered Outcomes Research Institute has approved a $2.1 million, three-year research award to The George Washington University Cancer Institute, housed within the GW School of Medicine and Health Sciences, and the GW School of Public Health and Health Services to evaluate cancer survivorship care models.
Researchers at Dana-Farber Cancer Institute have developed a novel method for determining how ready acute myeloid leukemia (AML) cells are to die, a discovery that may help cancer specialists to choose treatments option more effectively for their patients who have AML.
› Verified 5 days ago
| Entity Name | Obhg Louisiana Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639567316 PECOS PAC ID: 9234443250 Enrollment ID: O20150805006718 |
News Archive
Improving diagnosis and treatment for individuals with autism has been the focus of a growing body of research. New information from these studies led the American Academy of Child and Adolescent Psychiatry to revise key parameters for evaluating and treating autism. Researchers led by Yale Child Study Center director Fred Volkmar, M.D., have published the new practice parameters in the Feb. issue of the Journal of the American Academy of Child and Adolescent Psychiatry.
A University of Colorado Cancer Center study published in the journal Pediatric Blood & Cancer shows that pediatric cancer patients who receive antibiotics within 60 minutes of reporting fever and showing neutropenia (low neutrophil count), go on to have decreased intensive care consultation rate and lower mortality compared with patients who receive antibiotics outside the 60-minute window.
With the number of deaths caused by high blood pressure on the rise in the United States, the American Medical Association is joining the American Heart Association to increase public awareness of this "silent killer."
The Patient-Centered Outcomes Research Institute has approved a $2.1 million, three-year research award to The George Washington University Cancer Institute, housed within the GW School of Medicine and Health Sciences, and the GW School of Public Health and Health Services to evaluate cancer survivorship care models.
Researchers at Dana-Farber Cancer Institute have developed a novel method for determining how ready acute myeloid leukemia (AML) cells are to die, a discovery that may help cancer specialists to choose treatments option more effectively for their patients who have AML.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Estelle Alexis Rutledge, MD 38 Villa Vista Loop, Little Rock, AR 72204-6708 Ph: (501) 960-1390 | Dr Estelle Alexis Rutledge, MD 38 Villa Vista Loop, Little Rock, AR 72204-6708 Ph: (501) 960-1390 |
News Archive
Improving diagnosis and treatment for individuals with autism has been the focus of a growing body of research. New information from these studies led the American Academy of Child and Adolescent Psychiatry to revise key parameters for evaluating and treating autism. Researchers led by Yale Child Study Center director Fred Volkmar, M.D., have published the new practice parameters in the Feb. issue of the Journal of the American Academy of Child and Adolescent Psychiatry.
A University of Colorado Cancer Center study published in the journal Pediatric Blood & Cancer shows that pediatric cancer patients who receive antibiotics within 60 minutes of reporting fever and showing neutropenia (low neutrophil count), go on to have decreased intensive care consultation rate and lower mortality compared with patients who receive antibiotics outside the 60-minute window.
With the number of deaths caused by high blood pressure on the rise in the United States, the American Medical Association is joining the American Heart Association to increase public awareness of this "silent killer."
The Patient-Centered Outcomes Research Institute has approved a $2.1 million, three-year research award to The George Washington University Cancer Institute, housed within the GW School of Medicine and Health Sciences, and the GW School of Public Health and Health Services to evaluate cancer survivorship care models.
Researchers at Dana-Farber Cancer Institute have developed a novel method for determining how ready acute myeloid leukemia (AML) cells are to die, a discovery that may help cancer specialists to choose treatments option more effectively for their patients who have AML.
› Verified 5 days ago
Dr. Francisco Batres, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 9101 Kanis Rd, Suite 300, Little Rock, AR 72205 Phone: 501-801-1200 Fax: 501-801-1207 | |
Dr. Kristin K Zorn, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000 | |
David Hutchins, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000 | |
Kristen Taylor Bracy, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9500 Baptist Health Dr Ste 100, Little Rock, AR 72205 Phone: 501-224-5500 Fax: 501-224-1166 | |
Dayna D Whitcombe, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6119 Midtown Ave, Little Rock, AR 72205 Phone: 501-296-1800 Fax: 501-296-1711 | |
Nafisa Dajani, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000 | |
Jennifer Afton Cooper, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5 Saint Vincent Cir Ste 300, Little Rock, AR 72205 Phone: 501-552-8800 Fax: 501-552-5343 |